<DOC>
	<DOCNO>NCT02578173</DOCNO>
	<brief_summary>Purpose : To evaluate accuracy AVERT PLUS monitor contrast volume use angiographic procedure . This first man prospective observational study accuracy system quantify contrast volume use clinically indicated angiography cardiac catheterization laboratory .</brief_summary>
	<brief_title>Evaluation Novel Method Contrast Volume Quantification - AVERT PLUS 2.0</brief_title>
	<detailed_description>Research Design : The AVERT PLUS FDA 510K clear device consist 1 ) contrast delivery modulator design reduce unnecessary contract dye delivery patient angiography ( coronary peripheral ) 2 ) concomitant contrast monitoring system precisely measure contrast volume deliver patient . This first man prospective observational study accuracy system quantify contrast volume use clinically indicated angiography cardiac catheterization laboratory .</detailed_description>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>Patients undergo clinically indicate coronary peripheral angiography</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>